These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6243453)

  • 21. Aminoglycoside cross-resistance patterns of gentamicin-resistant bacteria.
    Houang ET; Greenwood D
    J Clin Pathol; 1977 Aug; 30(8):738-44. PubMed ID: 413843
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.
    Reyonolds AV; Hamilton-Miller JM; Brumfitt W
    J Infect Dis; 1976 Nov; 134 SUPPL():S291-6. PubMed ID: 62815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and characterization of resistance to gentamicin in gram-negative bacteria.
    Suenderhauf U; Kayser FH; Waespe B
    Microbios; 1976; 17(70):221-30. PubMed ID: 829605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Inactivation of aminoglycoside antibiotics by clinically isolated Pseudomonas aeruginosa].
    Sato K; Kurimoto T; Okachi R
    Jpn J Antibiot; 1983 Jan; 36(1):194-8. PubMed ID: 6405063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminoglycoside-selected subpopulations of Pseudomonas aeruginosa: characterization and virulence in normal and leukopenic mice.
    Gerber AU; Craig WA
    J Lab Clin Med; 1982 Nov; 100(5):671-81. PubMed ID: 6813409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.
    Hirai K; Suzue S; Irikura T; Iyobe S; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Apr; 31(4):582-6. PubMed ID: 3111356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pseudomonas aeruginosa plasmids that control streptomycin resistance].
    Boronin AM; Anisimova LA; Stepanshina VN; Ganelin VL
    Antibiotiki; 1979 Aug; 24(8):585-90. PubMed ID: 114103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa.
    Galbraith L; Wilkinson SG; Legakis NJ; Genimata V; Katsorchis TA; Rietschel ET
    Ann Microbiol (Paris); 1984; 135B(2):121-36. PubMed ID: 6439097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosa.
    Karlowsky JA; Saunders MH; Harding GA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1387-93. PubMed ID: 8726006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to aminoglycoside antibiotics.
    Ramírez-Ronda CH; Nevárez M; Gutiérrez-Núñez JJ; Reyes Y
    Bol Asoc Med P R; 1983 Jul; 75(7):305-7. PubMed ID: 6442865
    [No Abstract]   [Full Text] [Related]  

  • 32. Mutations in Gene
    Bolard A; Plésiat P; Jeannot K
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients.
    Shahid M; Malik A
    Indian J Med Res; 2005 Oct; 122(4):324-9. PubMed ID: 16394325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic resistance patterns during aminoglycoside restriction.
    Young EJ; Sewell CM; Koza MA; Clarridge JE
    Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation of Pseudomonas aeruginosa specifying reduced affinity for penicillin G.
    Godfrey AJ; Bryan LE
    Antimicrob Agents Chemother; 1982 Feb; 21(2):216-23. PubMed ID: 6803665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection of aminoglycoside-resistant variants of Pseudomonas aeruginosa in an in vivo model.
    Gerber AU; Vastola AP; Brandel J; Craig WA
    J Infect Dis; 1982 Nov; 146(5):691-7. PubMed ID: 6813385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. R factor-mediated aminoglycoside antibiotic resistance in Pseudomonas aeruginosa: a new aminoglycoside 6'-N-acetyltransferase.
    Kawabe H; Kondo S; Umezawa H; Mitsuhashi S
    Antimicrob Agents Chemother; 1975 May; 7(5):494-9. PubMed ID: 807154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered denA and anr gene expression in aminoglycoside adaptive resistance in Pseudomonas aeruginosa.
    Karlowsky JA; Hoban DJ; Zelenitsky SA; Zhanel GG
    J Antimicrob Chemother; 1997 Sep; 40(3):371-6. PubMed ID: 9338489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.
    Watanakunakorn C; Kauffman CA
    Infection; 1978; 6(3):111-5. PubMed ID: 98451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TpiA is a Key Metabolic Enzyme That Affects Virulence and Resistance to Aminoglycoside Antibiotics through CrcZ in Pseudomonas aeruginosa.
    Xia Y; Wang D; Pan X; Xia B; Weng Y; Long Y; Ren H; Zhou J; Jin Y; Bai F; Cheng Z; Jin S; Wu W
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.